Vanda Pharmaceuticals settles Fanapt® patent litigation with Apotex
Vanda Pharma announced it has entered into a License Agreement with Apotex to resolve Vanda's patent litigation against Apotex regarding Apotex's aNDA seeking approval of its generic version of Vanda's Fanapt® (iloperidone). Vanda Grants Apotex a license to sell generic Fanapt® beginning Nov. 2027. December 07, 2016